Mark Walsh, Hau Kwaan, Ross McCauley, Mathew Marsee, Jacob Speybroeck, Scott Thomas, Jordan Hatch, Stefani Vande Lune, Anne Grisoli, Sarah Wadsworth, Faisal Shariff, John G Aversa, Faadil Shariff, Nuha Zackariya, Rashid Khan, Vanessa Agostini, Elena Campello, Paolo Simioni, Escaterina Scărlătescu, Jan Hartmann
The quantification of the coagulopathic state associated with oncologic and hematologic diseases is imperfectly assessed by common coagulation tests such as prothrombin time, activated partial thromboplastin time, fibrinogen levels, and platelet count. These tests provide a static representation of a component of hemostatic integrity, presenting an incomplete picture of coagulation in these patients. Viscoelastic tests (VETs), such as rotational thromboelastometry (ROTEM) and thromboelastography (TEG), as whole blood analyses, provide data related to the cumulative effects of blood components and all stages of the coagulation and fibrinolytic processes...
October 2020: Transfusion